HeartCare Medical-B (06609.HK) Announces H-Share Repurchase Plan of Up to HK$100 Million

Zhitong Finance APP News: HeartCare-B (06609) announced that the Board of Directors, after comprehensive consideration of the Group’s current operational status, financial condition, and future development prospects, believes that the current trading price of its shares fails to reflect their intrinsic value. The repurchase of H-shares under the current market conditions demonstrates the Company’s confidence in its business outlook and growth. The Board has reviewed and approved an H-share repurchase plan with a total amount not exceeding HK$100 million, to repurchase no more than 1 million H-shares pursuant to the repurchase mandate.

The H-share repurchase program will be fully funded by the Company’s internal resources to ensure financial stability, without reliance on external financing. The H shares repurchased under the H-share repurchase program may be held as treasury shares or cancelled in accordance with the Listing Rules and any other applicable rules and regulations.